iRhythm Technologies Inc (IRTC)


Stock Price Forecast

March 28, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading iRhythm Technologies Inc chart...

About the Company

irhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ecg, monitoring for patients at risk for arrhythmias. we have created a unique platform, zio by irhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.

CEO

Kevin King

Exchange

NASDAQ

Website

https://www.irhythmtech.com/

$492M

Total Revenue

1K

Employees

$4B

Market Capitalization

-31.04

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $IRTC News

IRTC LAWSUIT ALERT: Levi & Korsinsky Notifies iRhythm Technologies, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

1d ago, source:

Levi & Korsinsky Notifies iRhythm Technologies, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline ...

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm

2d ago, source:

If you suffered losses exceeding $100,000 investing in iRhythm stock or options between January 11, 2022, and May 30, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner ...

IMMINENT IRTC DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds iRhythm Technologies, Inc. Investors to Join the Class Action Lawsuit!

1d ago, source: Stockhouse

Throughout the Class Period, iRhythm represented to investors that the Zio AT monitor was a real-time monitor intended for a target audience of high-risk patients. The Company's legacy monitor and ...

IRTC Jan 2025 80.000 put

13d ago, source: Yahoo Finance

SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, ...

Insider Sell: EVP, CMO & CSO Minang Turakhia Sells 943 Shares of iRhythm Technologies Inc (IRTC)

23d ago, source:

Rhythm Technologies Inc (NASDAQ:IRTC) is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining its wearable biosensing technology with cloud-based ...

Deal Watch: Big Energy and Pharma Deals Continue to Drive M&A

9d ago, source:

Five of the six announced deals over $1 billion in the last week occurred in either the life sciences or energy sector.

iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029

24d ago, source:

SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, ...

Rockwell Medical, Inc. (NASDAQ:RMTI) Q4 2023 Earnings Call Transcript

6d ago, source: Hosted on MSN

Rockwell Medical, Inc. (NASDAQ:RMTI) Q4 2023 Earnings Call Transcript March 21, 2024 Rockwell Medical, Inc. beats earnings ...

LivaNova gains after positive predictive outcome of sleep apnea study

on MSN ago, source:

Shares of LivaNova (LIVN) surged after positive outcomes were reported in the OSPREY clinical study for obstructive sleep apnea treatment.

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm

3d ago, source:

If you suffered losses exceeding $100,000 investing in iRhythm stock or options between January 11, 2022, and May 30, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...